Does low libido in women come down to hormones?
Quick answer
Testosterone therapy for female hypoactive sexual desire disorder is supported by a meaningful evidence base in peri- and postmenopausal women, with the 2019 Global Consensus Position Statement (Davis et al., Journal of Sexual Medicine) recommending it following a thorough clinical assessment and after excluding other contributing causes. Androfem is used off-label in Australia for this purpose and requires baseline hormonal testing, dosing oversight, and ongoing monitoring for androgenic side effects including acne, hirsutism, and voice changes. Evidence for testosterone improving energy or general wellbeing independent of sexual function remains inconsistent and should not be presented as established benefit.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @narellan.medical.s actually say?
Dr Anna Pham, a GP based in South West Sydney, argues that many women with persistent low libido may have undiagnosed low testosterone, and that testosterone supplementation, specifically a cream called Androfem, can be genuinely life-changing. She frames it as a last resort after sleep, stress, and relationship factors have been ruled out, and insists on medical supervision, baseline testing, and ongoing monitoring before anyone starts. She also clarifies that Australia does not use testosterone injections for women, preferring cream for dose control and a lower side-effect profile.
She name-drops "Lotus Docerone" near the end, which appears to be a mispronunciation or verbal slip, likely meaning low-dose testosterone. It is worth flagging because a viewer might search that term and find nothing useful.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Does low libido in women come down to hormones?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Does low libido in women come down to hormones? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone therapy for female hypoactive sexual desire disorder is supported by a meaningful evidence base in peri- and postmenopausal women, with the 2019 Global Consensus Position Statement (Davis et al.
FormBlends verdict
Testosterone therapy for female hypoactive sexual desire disorder is supported by a meaningful evidence base in peri- and postmenopausal women, with the 2019 Global Consensus Position Statement (Davis et al., Journal of Sexual Medicine) recommending it following a thorough clinical assessment and after excluding other contributing causes. Androfem is used off-label in Australia for this purpose and requires baseline hormonal testing, dosing oversight, and ongoing monitoring for androgenic side effects including acne, hirsutism, and voice changes. Evidence for testosterone improving energy or general wellbeing independent of sexual function remains inconsistent and should not be presented as established benefit.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone therapy for female hypoactive sexual desire disorder is supported by a meaningful evidence base in peri- and postmenopausal women, with the 2019 Global Consensus Position Statement (Davis et al., Journal of Sexual Medicine) recommending it following a thorough clinical assessment and after excluding other contributing causes. Androfem is used off-label in Australia for this purpose and requires baseline hormonal testing, dosing oversight, and ongoing monitoring for androgenic side effects including acne, hirsutism, and voice changes. Evidence for testosterone improving energy or general wellbeing independent of sexual function remains inconsistent and should not be presented as established benefit.
- The 2019 Global Consensus Position Statement, backed by over 40 RCTs, supports testosterone therapy for HSDD in postmenopausal women, making this a legitimate clinical tool, not a fringe intervention.
- Evidence for testosterone improving energy or mood in women is inconsistent. A 2014 Cochrane review found no reliable benefit outside of sexual function, so claims about general wellbeing should be treated with skepticism.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The 2019 Global Consensus Position Statement, backed by over 40 RCTs, supports testosterone therapy for HSDD in postmenopausal women, making this a legitimate clinical tool, not a fringe intervention.
- Evidence for testosterone improving energy or mood in women is inconsistent. A 2014 Cochrane review found no reliable benefit outside of sexual function, so claims about general wellbeing should be treated with skepticism.
- Androfem is used off-label in Australia for female HSDD. It is not TGA-approved specifically for this indication, which is something patients should be told before starting treatment.
- Even low-dose transdermal testosterone can cause acne, increased body hair, and, at elevated doses, irreversible voice deepening. Monitoring testosterone levels is not optional, it is how you avoid harm.
- Thyroid dysfunction, iron deficiency anaemia, and SSRI or SNRI use are common and underdiagnosed causes of low libido in women. These should be excluded before attributing symptoms to testosterone deficiency.
- The transcript includes an apparent verbal slip referencing 'Lotus Docerone,' which is not a recognized clinical term. Viewers searching this term will find nothing, and the confusion could delay someone getting appropriate care.
- Self-treating with testosterone products purchased outside a regulated medical pathway carries real risks including dosing errors, contamination, and no monitoring. A GP consultation is the appropriate first step.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Narellan Medical + Skin · TikTok creator
6.3K views on this video
Low libido… and no one talks about it? You’ve fixed your sleep. Managed the stress. The relationship is solid. But the desire just isn’t there. For some women, it’s not “in your head.” It’s hormones. #narellan #womenshealth #lowlibido ----- The information contained in this video and across all content is general advice. It is best to consult with your doctor for your specific needs.
Not medical advice. This video was made by Narellan Medical + Skin, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.